Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction

Circulation

Volumn 96, Issue 8, 1997, Pages 2520-2525

  Gaziano, J Michael ^a,d   Hennekens, Charles H ^a,b,c   O'Donnell, Christopher J ^f   Breslow, Jan L ^e   Buring, Julie E ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d VA BOSTON HEALTHCARE SYSTEM   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f FRAMINGHAM HEART STUDY   (United States)

Author keywords

Coronary disease; Infarction; Lipoproteins; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; FEMALE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030869156     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2520     Document Type: Article

References (32)

1. Gotto AM. Interrelationship of triglycerides with lipoproteins and High-density lipoproteins. Am J Cardiol. 1990;66:20A-23A.
2. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pagoda JM, Labree L, Hemphill LC, Kramsch DM, Blankenhorn DH. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/ moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation. 1994;90:42-49.
3. Hodis HN, Mock WJ. Triglyceride-rich lipoproteins and progression of coronary artery disease. Curr Opin Lipid. 1995;6: 209-214.
4. Bissett JK, Wyeth RP, Matts JP, Johnson JW, the POSCH Group Plasma lipid concentrations and subsequent coronary occlusion after a first myocardial infarction. Am J Med Sci 1993;305:139-144.
5. Krauss RM, Williams PT, Brensike J, Detre KM, Lindgren FT, Kelsey SF, Vranizan K, Levy RI. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet. 1987;62-66.
6. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. NIH Consensus Conference: Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA. 1993;269:505-510.
7. Hulley SB, Roseman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med. 1980;302:1383-1389.
8. Austin MA. Plasma triglyceride as a risk factor for coronary artery disease: the epidemiologic evidence and beyond. Am J Epidemiol. 1989;129:249-259.
9. Reaven GM. Are triglycerides important as a risk factor for coronary disease? Heart Dis Stroke. 1993;2:44-48.
10. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor lor cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
11. Crique MH, Heiss G, Cohn R, Cowan LD, Suchindran CM Bangdiwala S, Kritchevsky S, Jacobs DR, O'Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993;328:1220-1225.
12. Jacobs DR, Barrett-Connor E. Retest reliability of plasma cholesterol and triglyceride: the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1982;116:878-885.
13. Cowam LD, Wilcosky T, Crique MH, Barett-Conner E, Suchindran CM, Wallace R, Laskarzewski P, Walden C. Demographic, behavioral, biochemical, and dietary correlates of plasma triglycerides: the Lipid Research Clinics Program Prevalence Study Arteriosclerosis. 1985;5:466-480.
14. Albrink MJ, Krauss RM, Lindgren FT, Von der Groeben J, Pan S, Wood PD. Intercorrelations among plasma high density lipoprotein obesity, and triglycerides in a normal population. Lipids. 1980;140:668-676.
15. Davis CE, Gordon D, LaRosa J, Wood PD, Halperin M Correlations of plasma high density lipoprotein cholesterol levels with othet plasma lipid and lipoprotein concentrations. Circulation. 1980;62(suppl IV):IV-24-IV-30.
16. West KM, Ahuja MMS, Bennett PH, Czyzyk A, DeAcosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Kroleski AS, Miki E, Schliack, Teuscher A, Watkins PJ, Stober JA. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 1983;15:15-19.
17. Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH. Decreased HDL2 and HDL3 cholesterol, apo A-I and apo-II, and increased risk of myocardial infarction. Circulation. 1992;85:22-29.
18. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and risk of myocardial infarction. N Engl J Med. 1993: 329:1829-1834.
19. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
20. Giovannucci E, Colditz G, Stampfer MJ, Rimm ER, Littin L, Sampson L, Willett WC. The assessment of alcohol consumption by a single self administered questionnaire. Am J Epidemiol. 1991;133: 810-817.
21. Haynes SG, Levin S, Scotch N, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study, I: methods and risk factors. Am J Epidemiol. 1978;107:362-383.
22. Lipid Research Clinics Program. Lipid Research Clinics Population Studies Data Book. Vol1. The Prevalence Study. Bethesda, Md: National Institutes of Health; 1980:28-81, NIH publication No. 80-1527.
23. Lipid Research Clinics Program. Manual of Operations. Vol. 1. Lipid and Lipoprotein Analysis. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 1975:51-59, DHEW publication No. 75-628.
24. Gidez LI, Liller GO, Burstein M, Slagle S, Elder HA. Separation and quantification of subclasses of human plasma high density lipoprotein by a simple precipitation procedure. J Lipid Res. 1982; 23:1206-1223.
25. Schlesselman JJ. Case-Control Studies. New York, NJ: Oxford University Press, 1982.
26. Cornfield J, Gordon T, Smith WW. Quantal response curves for experimentally uncontrolled variables. Bull Intern Stat. 1961;38: 97-115.
27. Heyden S, Heiss G, Hames G, Bartel AG. Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia. J Chronic Dis. 1980;33:275-282.
28. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986;112:432-437.
29. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and non-lipid factors. Circulation. 1990;81:470-476.
30. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1922.
31. Eisenberg S, Gavish D, Oschury Y, Fainaru M, Deckelbaum RJ. Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia: reversal toward normal with bezafibrate treatment. J Clin Invest. 1984;74:470-482.
32. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol apolipoproteins and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.